Comment on âSustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trialâ by Tanaka et al
Berkhout, Lea C, l'Ami, Merel J, Wolbink, Gerrit Jan, Rispens, TheoJournal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2019-216557
Date:
November, 2019
File:
PDF, 228 KB
2019